One World Cannabis Begins Multiple Myeloma Study

OWC Pharmaceutical Research Corp. (OTC: OWCP), a developer of medical cannabis treatments and provider of regulatory consulting services, recently announced that it began a basic science study several weeks ago at the Sheba Academic Medical Center Multiple Myeloma Research Lab in accordance with the Sheba Internal Review Board approval that it received earlier this year. “We are…

The post One World Cannabis Begins Multiple Myeloma Study appeared first on Marijuana Index.